Abarceo Pharma AB

Abarceo Pharma is developing a small molecule technology platform for the treatment of mitochondrial dysfunction, with an initial focus on T2D.

KONTAKT
Adam Bruce 
E adam.bruce@abarceo.com
W www.abarceo.se

ADRESS
Abarceo Pharma AB
Medeon Science Park
SE-205 12 Malmö